Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
02/2010
02/25/2010CA2735130A1 Compounds and methods for treating respiratory diseases
02/25/2010CA2734126A1 Metal complex and manufacturing method therefor
02/24/2010EP2155736A1 Novel carbamoyloxy arylalkanoyl arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound
02/24/2010EP2155683A2 Pyridone derivatives as p38a mapk inhibitors
02/24/2010EP2155682A2 Salts of isophosphoramide mustard and analogs thereof
02/24/2010EP2155681A1 Process for the preparation of compositions for modulating a kinase cascade and methods of use thereof
02/24/2010EP2155680A1 Indanone derivatives that inhibit prolyl hydroxylase
02/24/2010EP2155675A1 Kinase inhibitors, compositions thereof, and methods of use therewith
02/24/2010EP2155643A1 Ire-1a inhibitors
02/24/2010EP2155194A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
02/24/2010EP2029596B1 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzothiazepines, the preparation and use thereof, and compositions containing the same
02/24/2010EP2001873B1 Active ingredient combinations with insecticidal properties
02/24/2010EP1599448B1 Preparation of 3,6-dichloro-2-trichloromethylpyridine by vapor phase chlorination of 6-chloro-2-trichlormethylpyridine
02/24/2010CN101657424A dual-acting antihypertensive agents
02/24/2010CN101657423A Iminipyridine derivatives and their uses as microbiocides
02/24/2010CN101654433A Method for N-alkylation of 2-pyridone
02/24/2010CN101654432A Method for N-alkylation of 2-pyridone
02/24/2010CN101654431A Method for synthesizing pyridine propiolic acid ester
02/24/2010CN101654430A Broadband electron transport material and preparation and application
02/24/2010CN100591745C 电致发光装置 Electroluminescent device
02/24/2010CN100591676C 2- and 2,5-substituted phenylketo-enols
02/24/2010CN100591671C Heteroarylcarbamoylbenzene derivative
02/23/2010US7667043 Molecular structures with controllable electron conducting properties
02/23/2010US7666884 N-(2-substituted phenyl)-N-methoxycarbamates and their preparation and use thereof
02/23/2010US7666883 2-[(2-Chloro-5-methyl pyridine-3-yl)(hydroxy)methyl]acrylonitrile; against chloroquine sensitive and chloroquine resistant Plasmodium falciparum; treating malarial; chemical preparation
02/23/2010US7666873 N-phenyl-(2R,5S)dimethylpiperazine derivative
02/23/2010US7666866 Antithrombotic diamides
02/23/2010US7666865 Calcium channel blockers
02/23/2010US7666442 Topical compositions comprising benfotiamine and pyridoxamine
02/23/2010CA2562216C Process for producing a trifluoro-3-buten-2-one compound
02/23/2010CA2345146C Cyanophenyl derivative
02/18/2010WO2010019828A1 Glucagon receptor antagonists
02/18/2010WO2010019701A2 Diaryl urea derivatives
02/18/2010WO2010019646A1 Sphingosine-1-phosphate (s1p) receptor antagonists and methods for use thereof
02/18/2010WO2010019398A1 Two phase bioactive formulations
02/18/2010WO2010018858A1 Organic sulfur compound, process for production of the same, and organic electroluminescence element utilizing the same
02/18/2010WO2010018857A1 Method for producing amide derivative
02/18/2010WO2010018714A1 Amide derivative, pest control agent containing the amide derivative and use of the pest control agent
02/18/2010WO2010018113A2 Bi-aryl aminotetralines
02/18/2010WO2010018109A2 Substituted aminotetralines
02/18/2010US20100041894 Eco-friendly process for recovery of pyridine and/or its derivatives
02/18/2010US20100041882 Methods for synthesis of acyloxyalkyl compounds
02/18/2010US20100041717 N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
02/18/2010US20100041715 Sphingosine-1-phosphate (s1p) receptor antagonists and methods for use thereof
02/18/2010US20100041714 Bi-aryl aminotetralines
02/18/2010US20100041713 Substituted aminotetralines
02/18/2010US20100041708 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for it's preparation
02/18/2010US20100041683 Novel chain-breaking antioxidants
02/18/2010US20100041656 Novel amide derivatives and medicinal use thereof
02/18/2010US20100041653 Composition and methods for the design and development of metallo-enzyme inhibitors
02/18/2010US20100040753 Flavor molecules
02/18/2010CA2735392A1 Bi-aryl aminotetralines
02/18/2010CA2734119A1 Two phase bioactive formulations
02/18/2010CA2734104A1 Substituted aminotetralines
02/18/2010CA2733970A1 Sphingosine-1-phosphate (s1p) receptor antagonists and methods for use thereof
02/18/2010CA2733557A1 Amide derivative, pest control agent containing the amide derivative, and use of the amide derivative
02/17/2010EP2154131A1 G protein-coupled receptor inhibitor and pharmaceutical product
02/17/2010EP2154130A1 Pyridone compound
02/17/2010EP2152671A1 Bicyclic aryl and heteroaryl compounds for the treatment of metabolic disorders
02/17/2010EP2152663A2 Tri-aryl compounds and compositions comprising the same
02/17/2010EP2152256A2 Telomerase activating compounds and methods of use thereof
02/17/2010EP1979321B9 Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them
02/17/2010EP1377263B1 Novel dyeing composition for dyeing keratinous fibres comprising a particular dicationic diazo dye
02/17/2010EP1347950B1 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of gamma-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses
02/17/2010CN101652347A Process for producing substituted methylamine compound and triazine derivative
02/17/2010CN101648912A Continuous preparation method of 4-nitro-3,5-dimethylpyridine-N-oxide
02/17/2010CN101648911A Purifying method of 4-nitro-3,5-dimethylpyridine-N-oxide
02/17/2010CN101648910A Method for preparing 3,5-dimethylpyridine-N-oxide
02/17/2010CN101648909A Method for preparing cyanopyridine by using chloropyridine under the catalysis of ligand-free palladium
02/17/2010CN101648908A New water-soluble rare-earth organic chelate fluorescent probe and preparation method thereof
02/17/2010CN101648907A Purifying method of 2-chloromethyl-4-methoxyl-3,5-dimethylpyridine chloride
02/17/2010CN101648906A Insecticidal N-substituted sulfoximines
02/17/2010CN101648905A Preparation method of 2- chloro-6-trichloromethyl pyridine
02/17/2010CN101648904A Synthesis method of 2,3-difluoro-5-chloropyridine
02/16/2010US7662987 Methods for synthesis of acyloxyalkyl compounds
02/16/2010US7662974 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same
02/16/2010US7662966 For example, 5-tert-Butyl-2-{2-[4-(1-methyl-piperidin-4-yl)-butoxy]-pyridin-4-yl}-1H-benzoimidazole; use in leukocyte recruitment inhibition, in modulating H4 receptor, and in treating conditions such as inflammation, H4 receptor-mediated conditions, and related conditions
02/16/2010US7662839 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); dysmenorrhoea, preterm labour, glaucoma, immune disorders, inflammatory disorders; e.g. {4-[(5-Phenyl-furan-2-carbonyl)-amino]-phenyl}-acetic acid
02/16/2010US7662822 Substituted azaquinazolines having an antiviral action
02/16/2010CA2478183C Substituted amides
02/16/2010CA2452918C New compounds, which are potent inhibitors of na+/ca2+ exchange mechanism and are useful in the treatment of arrhythmias
02/16/2010CA2445329C 20-hydroxyeicosatetraenoic acid production inhibitors
02/16/2010CA2442882C Sulphones which modulate the action of gamma-secretase
02/16/2010CA2385081C Carboxylic acid compound and a medicament comprising it
02/11/2010WO2010017350A1 Aminopyridine kinase inhibitors
02/11/2010WO2010017343A2 Flupirtine hydrochloride maleic acid cocrystal
02/11/2010WO2010017260A1 Tripyridyl carboxamide orexin receptor antagonists
02/11/2010WO2010017060A1 Urea derivatives as antibacterial agents
02/11/2010WO2010017051A1 Novel phenylamino isonicotinamide compounds
02/11/2010WO2010015655A1 Cyclohexyl amide derivatives and their use as crf-1 receptor antagonists
02/11/2010WO2010015613A1 Organic compounds
02/11/2010WO2010015387A1 Daa-pyridine as peripheral benzodiazepine receptor ligand for diagnostic imaging and pharmaceutical treatment
02/11/2010WO2010015340A1 Daa-pyridine as peripheral benzodiazepine receptor ligand for diagnostic imaging and pharmaceutical treatment
02/11/2010US20100036130 Processes for producing cycloalkylcarboxamido-pyridine benzoic acids
02/11/2010US20100036119 Fluorinating reagents and their preparation
02/11/2010US20100036115 Novel Compositions for the Delivery of Negatively Charged Molecules
02/11/2010US20100036102 Novel chelating agents and highly luminescent and stable chelates and their use
02/11/2010US20100035938 Cooling Compounds
02/11/2010US20100035936 Heterocyclyl substituted tetrahydronaphthalene derivatives as 5-ht7 receptor ligands
02/11/2010US20100035930 UREA AND SULFAMIDE DERIVATIVES AS INHIBITORS OF TAFIa